HC Wainwright Has Pessimistic Outlook of Merus Q2 Earnings
Merus (NASDAQ:MRUS – Free Report) – Equities researchers at HC Wainwright dropped their Q2 2025 earnings per share estimates for Merus in a research report issued to clients and investors on Thursday, May 8th. HC Wainwright analyst A. Fein now forecasts that the biotechnology company will earn ($1.28) per share for the quarter, down from […]
